ropivacaine

1
Reactions 900 - 4 May 2002 Ropivacaine Neurological disorders: case report The use of perioperative ropivacaine in a 58-year-old man undergoing radical prostatectomy was associated with the development of neurological disorders. The man received 7ml of epidural ropivacaine 0.75% for T10 level analgesia, after receiving a test dose of lidocaine/ epinephrine [adrenaline]. His current medication was bisoprolol. One hour after his first ropivacaine dose, a continuous epidural infusion of ropivacaine 0.2% was started at a rate of 5 ml/h. Ten hours later, the infusion rate was increased to 7 ml/h, and he received a single dose of proparacetamol for slight pain. He received epidural analgesia for a total of 72 hours. The man experienced a violent, bilateral burning sensation and pain in his back and thighs 12 hours after ropivacaine was discontinued. These sensations quickly spread to his legs and feet, and the pain was exacerbated by lower extremity movement, external pressure and his orthostatic position. He received SC morphine and IV ketoprofen, and his symptoms resolved within 12 hours. He did not experience any further neurological disorders during 2 weeks’ follow-up. Author comment: ‘During epidural anaesthesia, the transmeningeal transfer of local anaesthetics may result in elevated intrathecal concentrations that probably contribute to TNM [transient neurological manifestations].’ Al-Nasser B, et al. Transient neurological manifestations after epidural analgesia with ropivacaine. Anaesthesia 57: 306-307, Mar 2002 - France 800899979 1 Reactions 4 May 2002 No. 900 0114-9954/10/0900-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

Upload: vuthu

Post on 18-Mar-2017

212 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Ropivacaine

Reactions 900 - 4 May 2002

Ropivacaine

Neurological disorders: case reportThe use of perioperative ropivacaine in a 58-year-old man

undergoing radical prostatectomy was associated with thedevelopment of neurological disorders.

The man received 7ml of epidural ropivacaine 0.75% for T10level analgesia, after receiving a test dose of lidocaine/epinephrine [adrenaline]. His current medication wasbisoprolol. One hour after his first ropivacaine dose, acontinuous epidural infusion of ropivacaine 0.2% was startedat a rate of 5 ml/h. Ten hours later, the infusion rate wasincreased to 7 ml/h, and he received a single dose ofproparacetamol for slight pain. He received epidural analgesiafor a total of 72 hours.

The man experienced a violent, bilateral burning sensationand pain in his back and thighs 12 hours after ropivacaine wasdiscontinued. These sensations quickly spread to his legs andfeet, and the pain was exacerbated by lower extremitymovement, external pressure and his orthostatic position. Hereceived SC morphine and IV ketoprofen, and his symptomsresolved within 12 hours. He did not experience any furtherneurological disorders during 2 weeks’ follow-up.

Author comment: ‘During epidural anaesthesia, thetransmeningeal transfer of local anaesthetics may result inelevated intrathecal concentrations that probably contribute toTNM [transient neurological manifestations].’Al-Nasser B, et al. Transient neurological manifestations after epidural analgesiawith ropivacaine. Anaesthesia 57: 306-307, Mar 2002 - France 800899979

1

Reactions 4 May 2002 No. 9000114-9954/10/0900-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved